Finance

Lists
HURA:NASDAQ
TuHURA Biosciences Inc
US$ १.४०
+०.७२%
(+०.०१००) 1D
नोभेम्बर १६, १०:०४:२६ GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for HURA...
Open
US$ १.४२
High
US$ १.४३
Low
US$ १.३१
Mkt. cap
८.९२ करोड
Avg. vol.
४.१३ लाख
Volume
२.३७ लाख
52-wk high
US$ ३.४३
52-wk low
US$ ०.४१
EPS
-US$ ०.५४
Beta
-०.२३
Shares outstanding
६.३७ करोड
No. of employees
२२
Open
US$ १.४२
High
US$ १.४३
Low
US$ १.३१
Mkt. cap
८.९२ करोड
Avg. vol.
४.१३ लाख
Volume
२.३७ लाख
52-wk high
US$ ३.४३
52-wk low
US$ ०.४१
EPS
-US$ ०.५४
Beta
-०.२३
Shares outstanding
६.३७ करोड
No. of employees
२२
News stories
From web sources and news partners
upi
upi
·
२६ मिनेट पहिले
KB Kookmin Bank debuts S&P 500-linked dollar deposit product
ChartMill
ChartMill
·
१ घण्टा पहिले
S&P 500 Premarket Losers on Nov. 16, 2026: COIN, LITE, COHR
FXEmpire
FXEmpire
·
१ घण्टा पहिले
Why The S&P 500 Could Fall 63% – And Still Only Be Fairly Valued
About TuHURA Biosciences Inc
CEO-
Employees२२
Founded१९९५
Headquartersताम्पा, फ्लोरिडा, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Analyst ratings
Based on 2 analysts giving stock ratings to HURA in the past 3 months
Buy
Buy
2
Hold
0
Sell
0
12-month forecast
Based on 2 Wall Street analysts offering 12 month price targets for HURA in the last 3 months.
Highest
Current US$ १.४०
US$ १०.०० (+६१४.२९%)
Average
US$ ९.०० (+५४२.८६%)
Lowest
US$ ८.०० (+४७१.४३%)
Analyst
Recommendation
Action
Price target
Projected
Date
Jason McCarthy
Maxim Group
Buy
Maintained
US$ ८.००
+४७१.४%
11/13/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
US$ १०.००
+६१४.३%
10/27/2026
Silvan Turkcan
Citizens JMP
Buy
Initiated
US$ ९.००
+५४२.९%
04/27/2026
Unknown Analyst
Citizens JMP
Buy
Initiated
US$ ९.००
+५४२.९%
04/27/2026
Michael King
Rodman & Renshaw
Buy
Initiated
US$ ७.००
+४००%
04/15/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
६०.५५ लाख
५२.३३ लाख
६६.२० लाख
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
२३.३८ लाख
२२.९७ लाख
२१.४३ लाख
१९.५६ लाख
Operating expense
८३.९४ लाख
७५.३० लाख
८७.६३ लाख
-
Total operating expenses
८३.९४ लाख
७५.३० लाख
८७.६३ लाख
५६.६१ लाख
Operating income
-८३.९४ लाख
-७५.३० लाख
-८७.६३ लाख
-
Other non operating income
१.८५ लाख
-
-
-
EBT including unusual items
-६७.६१ लाख
-७५.३७ लाख
-९२.२३ लाख
-
EBT excluding unusual items
-८८.१७ लाख
-७५.३७ लाख
-९२.२३ लाख
-
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-६७.६१ लाख
-७५.३७ लाख
-९२.२३ लाख
-६४.१० लाख
Net profit margin
-
-
-
-
Earnings per share
-०.१६
-०.१३
-
-०.१०
Interest and investment income
६०९.००
२१.२८ हजार
७.६२ हजार
-
Interest expense
-६.०९ लाख
-२७.९७ हजार
-४.६८ लाख
-७.५३ लाख
Net interest expenses
-६.०८ लाख
-६.७० हजार
-४.६० लाख
-
Depreciation and amortization charges
-
-
-
-
EBITDA
-८३.७१ लाख
-७५.०६ लाख
-८७.३५ लाख
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू